Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Client, organization or corporation number: 371
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (921)
Results: 1-50 | Export
  1. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-05-28
    Posted: 2024-06-14
    Designated public office holders:
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • International Trade
    • Intellectual Property
    • Taxation and Finance
    • Consumer Issues
    • Science and Technology
    • Federal-Provincial Relations
    • Research and Development
    • Health
      •
  2. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-05-23
    Posted: 2024-06-14
    Designated public office holders:
    • Earl Dreeshen, Member of Parliament | House of Commons
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    • Blaine Calkins, Member of Parliament | House of Commons
    • Tom Kmiec, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • Health
    • Taxation and Finance
    • Small Business
    • Industry
    • Research and Development
    • Federal-Provincial Relations
    • Intellectual Property
    • International Trade
    • Consumer Issues
    • Agriculture
      •
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-05-23
    Posted: 2024-06-14
    Designated public office holders:
    • Max Valiquette, Executive Director of Communications | Prime Minister's Office (PMO)
    Subject matters:
    • Health
    • Science and Technology
    • Intellectual Property
    • Consumer Issues
    • Taxation and Finance
    • International Trade
    • Research and Development
    • Federal-Provincial Relations
      •
  4. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-05-07
    Posted: 2024-06-14
    Designated public office holders:
    • Desiree Sam, Parliamentary Secretary Assistant | Health Canada (HC)
    • Yasir Naqvi, Member of Parliament, Parliamentary Secretary to the Minister of Health | House of Commons
    Subject matters:
    • Intellectual Property
    • Research and Development
    • Science and Technology
    • Consumer Issues
    • Small Business
    • Health
    • Federal-Provincial Relations
    • Industry
    • Foreign Affairs
    • International Trade
    • Taxation and Finance
      •
  5. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-05-06
    Posted: 2024-06-14
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Consumer Issues
    • Science and Technology
    • International Trade
    • Health
    • Research and Development
    • Industry
    • Federal-Provincial Relations
    • Taxation and Finance
    • Intellectual Property
    • Small Business
      •
  6. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-04-15
    Posted: 2024-05-14
    Designated public office holders:
    • Mark Schaan, Senior Assistant Deputy Minister, Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Federal-Provincial Relations
    • Industry
    • International Trade
    • Health
    • Science and Technology
    • Intellectual Property
    • Small Business
    • Foreign Affairs
    • Taxation and Finance
    • Infrastructure
    • Research and Development
      •
  7. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-04-15
    Posted: 2024-05-14
    Designated public office holders:
    • Brian Masse, Member of Parliament | House of Commons
    Subject matters:
    • Science and Technology
    • International Trade
    • Foreign Affairs
    • Taxation and Finance
    • Research and Development
    • Small Business
    • Infrastructure
    • Health
      •
  8. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-04-15
    Posted: 2024-05-14
    Designated public office holders:
    • Francis Bilodeau, Associate Deputy Minister, Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Étienne-René Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • International Trade
    • Intellectual Property
    • Science and Technology
    • Industry
    • Foreign Affairs
    • Taxation and Finance
    • Research and Development
    • Infrastructure
    • Federal-Provincial Relations
    • Health
    • Small Business
      •
  9. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-03-01
    Posted: 2024-04-12
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  10. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-18
    Posted: 2024-02-12
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  11. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-11
    Posted: 2024-02-12
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  12. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-05
    Posted: 2024-02-12
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
      •
  13. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
      •
  14. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Jennifer Miller , Assistant Secretary | Privy Council Office (PCO)
    Subject matters:
    • Health
      •
  15. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Jean-Sebastien Bock, Deputy Chief of Staff, Office of the Minister of Health | Health Canada (HC)
    • Ehsan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  16. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-08
    Posted: 2024-01-15
    Designated public office holders:
    • Ehsan Naik , Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  17. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Gigi Osler, Senator | Senate of Canada
    Subject matters:
    • Health
    • Industry
      •
  18. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada
    • Sarah Polowin, Director of Parliamentary Affairs | Senate of Canada
    Subject matters:
    • Health
    • Industry
      •
  19. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Sébastien Lemire, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  20. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Health
    • Industry
      •
  21. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Helena Jaczek, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
    • Science and Technology
      •
  22. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Robert Kitchen, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
    • Science and Technology
      •
  23. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Luc Thériault, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  24. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Marie-Françoise Mégie, Senator | Senate of Canada
    Subject matters:
    • Health
    • Industry
      •
  25. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Jessica LaForge, Policy Advisor | Pacific Economic Development Canada (PacifiCan)
    • Gurjiven Sandhu, Director of Policy | Pacific Economic Development Canada (PacifiCan)
    Subject matters:
    • Health
    • Regional Development
    • Science and Technology
      •
  26. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Sharon Burey, Senator | Senate of Canada
    Subject matters:
    • Health
      •
  27. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Jennifer Miller , Assistant Secretary | Privy Council Office (PCO)
    • Jeff Warning, Associate Assistant Secretary | Privy Council Office (PCO)
    • Alexis Conrad, Assistant Secretary to the Cabinet | Privy Council Office (PCO)
    Subject matters:
    • Health
    • Industry
      •
  28. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Francis Scarpaleggia, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  29. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Chris Zhou, Senior Policy and Atlantic Advisor, Office of the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Rechie Valdez, Member of Parliament and Minister of Small Business | House of Commons
    Subject matters:
    • Health
    • Industry
    • Small Business
      •
  30. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Ehsan Naik , Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  31. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Corey Tochor, Member of Parliament | House of Commons
    • James Hawkes, Parliamentary Assistant | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  32. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Layla Platt, Executive Assistant | Employment and Social Development Canada (ESDC)
    • Christopher Evelyn, Chief of Staff to the Minister of Families, Children & Social Development | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Industry
    • Health
    • Small Business
    • Science and Technology
      •
  33. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Pamela Aung-Thin , Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  34. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
      •
  35. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Carol Hughes, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  36. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Chandra Arya, Member of the House of Commons | House of Commons
    Subject matters:
    • Health
      •
  37. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada
    Subject matters:
    • Industry
    • Health
    • Science and Technology
      •
  38. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Andrew Cardozo, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
      •
  39. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Francesco Sorbara, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
      •
  40. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Valerie Bradford, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  41. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  42. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Health
      •
  43. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Stan Kutcher, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
      •
  44. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
      •
  45. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-01
    Posted: 2023-12-08
    Designated public office holders:
    • Eshan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Ophelia John , Senior Policy Advisor, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  46. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-10-05
    Posted: 2023-11-10
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  47. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-10-04
    Posted: 2023-11-10
    Designated public office holders:
    • Jean Sebastien Bock, Deputy Chief of Staff, Office of the Minister of Health | Health Canada (HC)
    • Mark Holland, Minister of Health | Health Canada (HC)
    • Ophelia John, Senior Policy Advisor, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  48. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-09-21
    Posted: 2023-10-11
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  49. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-09-14
    Posted: 2023-10-11
    Designated public office holders:
    • Pamela Aung-Thin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  50. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-08-23
    Posted: 2023-09-14
    Designated public office holders:
    • Nancy Hamzawi, Executive Vice-President | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Industry
    • Health
      •
Date Modified: